Doxorubicin Recruiting Phase 1 Trials for Liver Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02753881Pharmacokinetics of Doxorubicin in cTACE of Liver Cancer